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Application of medicinal plants in several 
dermatovenerological entities
Treatment of skin conditions with medicinal plants has been 
an ongoing human activity lasting over thousands of years. 
The use of specific plant species developed regionally, based 
on local flora. Commonly used medicinal plants for derma-
to logical complaints are: Phlebodium aureum (L.) J. Sm., Ginkgo 
biloba L., Rosmarinus officinalis L., Panax ginseng C.A.Mey., Al­
lium cepa L.,  Aloe vera (L.) Burm.f., Capsicum annuum L., Ber­
be ris aquifolium Pursh, Camellia sinensis (L.) Kuntze, and 
Podophyllum peltatum L.
The demand for complementary therapeutics is an emerging 
trend due to the awareness of potential side effects that 
synt he tic drugs might cause. More scientific evidence and 
better documentation are needed before advising derma to-
lo gic patients on herbal medicinal treatment. Standardised 
ex tracts and formulations with proven clinical efficacy 
should be developed for this cause. Here provided review 
entails the use of herbal medicinal products in the treatment 
of frequent chronic skin diseases, such as vitiligo, alopecia, 
psoriasis and genital warts.
Keywords: medicinal plants, vitiligo, alopecia, psoriasis, 
ge ni tal warts
INTRODUCTION
Medicinal plants have been utilized for the treatment of various skin diseases in folk 
medicine. Species from local flora were used along with certain medicinal plants that were 
acquired through trade. In the recent years, research on medicinal plants and their bioactive 
compounds is growing in importance since chronic skin diseases, such as vitiligo, alopecia, 
psoriasis and genital warts, seem to be fairly resistant to the conventional treatment.
Vitiligo
Vitiligo is a common autoimmune pigmentation disorder affecting 0.5–4 % of the 
population. Current treatment options include topical application of corticosteroids, calci-
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neurin inhibitors, vitamin D analogues, phototherapy, laser therapy and surgery (1). Since 
the treatment results are often slow and unsatisfactory, with possible side effects, there is 
a great interest in complementary treatment modalities, such as medicinal plants.
Phlebodium aureum (L.) J. Sm. (Polypodium leucatomos Poir.), Polypodiaceae. – Dietary 
supplement containing P. aureum extract has been used for more than 30 years (1). Primary 
bioactive compounds are phenolic acids (2). When used in combination with narrow band 
(nb) UVB light (311 nm) or psoralen + UVA (PUVA) therapy, P. aureum supplementation 
may improve re-pigmentation and provide photoprotection (1). The results of a study 
which compared supplementation with 250 mg of P. aureum three times daily in combination 
with nb-UVB to placebo and nb-UVB, re-pigmentation of head and neck area was achieved 
in 44 % of patients in P. aureum group and in 27 % of patients in the control group. P. aureum 
supplementation prevented oxidative damage, especially in lighter skin type patients with 
lower baseline antioxidant capacity (3). A similar study was conducted on 57 patients with 
generalized vitiligo, but the dosage of P. aureum was 480 mg daily. Improvement was 
reported for 47.8 % of the patients in the P. aureum and nb-UVB group, and 22 % of patients 
with nb-UVB alone (4). The randomized study investigated the use of PUVA plus P. aureum, 
in comparison to placebo. More than 50 % of re-pigmentation was reported for the patients 
in the P. aureum group. The threshold of 50 % re-pigmentation was not achieved in the 
placebo group. Additionally, the immunomodulatory effect was shown by lymphocyte 
ratio normalization in the P. aureum group (5).
P. aureum demonstrated photoprotective activity in another study where the severity 
of erythema, pyrimidine dimer formation and epidermal proliferation were evaluated 
post-exposure to UV light. Pre-exposure supplementation with an oral dose of 7.5 mg kg–1 
of P. aureum decreased the UV light-induced damage (6). The toxicity of oral administrated 
P. aureum was minimal, reported adverse reactions include mild pruritus and gastro-
intestinal upset (1).
Ginkgo biloba L., Ginkgoaceae. – G. biloba is a medicinal plant originating from Traditional 
Chinese Medicine shown to inhibit disease progression and augment re-pigmentation in 
vitiligo (1). The observed benefits are due to the anti-inflammatory, antioxidant and anxiolytic 
activity of flavonoids and terpene trilactones present in the leaves.
A double-blind study investigated the effects of supplementation with 40 mg kg-1 of 
G. biloba extract in patients with limited, slow-spreading vitiligo. A significant arrest of 
active disease was reported, re-pigmentation was achieved in 40 % of treated patients 
compared with 9 % of patients in the control group. A common side effect is gastrointesti-
nal upset, but care should be taken because there have also been reports of haemorrhage 
and increased bleeding time (7).
Alopecia
Depending on its acuity and extent, hair loss is an important cause of anxiety.
Essential oils mixture. – A double-blind study included 86 patients with alopecia areata 
to investigate the efficacy of a mixture of essential oils as alopecia areata treatment. 
Selected essential oils for the mixture were obtained from: Thymus vulgaris L., Lavandula 
angustifolia Mill., Rosmarinus officinalis L. and Cedrus atlantica (Endl.) Manetti ex Carrière. 
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The mixture was diluted in carrier oil, a combination of grape seed and jojoba oil. Prepared 
oily mixture was administered daily and massaged into the scalp. The control group 
followed the same routine using only carrier oil. The treatment group had statistically 
significant improvement by 44 %, based on expert and computerized analyses of sequential 
photographs, comparing to the control group with 15 % improvement. There were no 
adverse effects reported (8).
Rosmarinus officinalis L., Lamiaceae. – R. officinalis is a well-known Mediterranean 
aromatic plant. The essential oil of R. officinalis improves microcirculation surrounding the 
hair follicle (9). Bioactive compounds of R. officinalis are phenolic acids, mainly caffeic and 
rosmarinic acid, and monoterpenoids like 1,8-cineole (10). A clinical study from 2015 com-
pared the efficacy of rosemary essential oil to minoxidil 2 % solution for the treatment of 
androgenetic alopecia. Patients used either minoxidil 2 % solution (n = 50) or rosemary 
essential oil (n = 50). Significant increase in hair count was reported for both treatments 
without significant difference between the study groups. Scalp irritation was more 
frequent in minoxidil 2 % solution group (9).
Panax ginseng C. A. Mey., Araliaceae. – Ginsenosides are saponin compounds derived 
from P. ginseng with a wide spectrum of biological activity, with the influence on hair-
growth being only one of the proposed activities (11). In 2014, a study was conducted in 
order to assess the efficacy of P. ginseng supplementation in treating female pattern 
alopecia. Group 1 consisted of patients who used topical 3 % minoxidil solution, while 
group 2 used topical 3 % minoxidil solution and oral P. ginseng supplement. An expert 
panel of dermatologists concluded that group 2 showed significantly better results 
although the hair density and thickness were improved in both groups (12).
Allium cepa L., Amaryllidaceae. – Sulphurous and phenolic compounds from onion 
juice act as irritants, thereby causing mild dermatitis which might provoke hair growth. A 
study where A. cepa juice was used as a treatment for alopecia areata has shown significantly 
more hair re-growth after six months of the treatment (86.9 %). The control group used 
only tap water and 13 % of hair re-growth was reported (13).
Psoriasis
Most studied medicinal preparations for the treatment of psoriasis are Aloe vera juice, 
capsaicin, indigo naturalis and Berberis aquifolium extracts (14).
Aloe vera (L.) Burm.f., Liliaceae. – A. vera has been used for medicinal purposes for more 
than 2000 years. Gel-like leaf juice of A. vera is a pharmaceutical material with reported anti-
inflammatory, antipruritic, and wound healing effects. Bioactive compounds of the juice are 
phenolics, polysaccharides, organic acids and various other metabolites (15).
A study with a group of patients who were treated with 0.5 % of A. vera juice in 
hydrophilic vehicle showed statistically significant improvement in the A. vera group 
compared to the group treated with hydrophilic vehicle exclusively. The A. vera juice 
caused a decrease in the severity of symptoms in 83.3 % of patients (16).
Capsicum annuum L., Solanaceae. – The main active ingredient of pepper extracts for 
topical application is capsaicin which inhibits transcription factors NF-κB and AP-1 
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activation in vitro (17). Substance P could play a role in neurogenic pathophysiology of 
psoriasis. In psoriatic plaques, substance P-activated inflammatory pathways can cause 
vasodilation and angiogenesis, followed by keratinocyte hyperproliferation. Capsaicin 
causes an efflux of substance P from sensory neurons by activating vanilloid receptors and 
thereby depleteing cutaneous substance P (14).
Topically used 0.025 % capsaicin cream has shown to improve symptoms like scaling 
and erythema in patients with moderate and severe psoriasis after 6 weeks of treatment 
(18). In another study, with the same dosage and duration of the treatment, along with 
improvements in scaling and erythema a significant decrease in thickness and pruritus 
are reported. The application of capsaicin is followed by an intense and short-lasting 
burning sensation (19).
Indigo naturalis. – Indigo naturalis is a preparation from Traditional Chinese Medicine 
usually obtained from plant species Strobilanthes cusia (Nees) Kuntze, Acanthaceae, and 
has long been used as a therapy for psoriasis and other conditions with an inflammatory 
component. Indirubin was identified as the active compound, besides the anti-inflammatory 
effect, inhibition of proliferation and promotion of differentiation in epidermal 
keratinocytes are proposed mechanisms of action (14).
Indigo naturalis ointment was studied as a topical therapy in moderate plaque 
psoriasis. After 8 weeks of randomized, double-blind, placebo-controlled clinical study, 
the results were quantified through Psoriasis Area Severity Index (PASI). Significant 
improvement by 75 % (PASI 75) had been achieved in 56.3 % of patients compared to 0.0 % 
in the placebo group. Additionally, in order to establish the exact mechanism, a biopsy was 
preformed showing the down-regulation of the IL-17 pathway (20). Lin et al. (21) reported 
a reduction of plaque area and significant improvement in symptoms after the treatment 
with an ointment containing indigo naturalis. In another study by Lin et al. (22) with the 
same indigo preparation, the PASI 75 was achieved in 74 % of patients in the treated group. 
Temporary erythema and itching on the application site were noted as adverse effects. Oily 
extract of indigo naturalis was formulated for a clinical study assessing the topical 
application in nail psoriasis and a significant improvement in the severity of symptoms 
was quantified with Nail Psoriasis Severity Index (NAPSI) after 12 and 24 weeks of 
treatments, without adverse effects (23).
Berberis aquifolium Pursh (Mahonia aquifolium (Pursh) Nutt.), Berberidaceae. – B. 
aquifolium use for the treatment of psoriasis is linked to the presence of berberine, an anti-
inflammatory alkaloid that reduces keratinocyte hyperproliferation markers typical for 
psoriasis (14, 24).
The extract of B. aquifolium formulated into a cream was tested in a clinical study for 
the treatment of chronic plaque psoriasis. Improvements in PASI score were significant in 
comparison to placebo cream (24). In another study, B. aquifolium extract was compared to 
conventional therapeutics calcipotriol and tazarotene; B. aquifolium extract was either as 
effective or better in treating disease symptoms (14).
Condyloma accuminata
Camellia sinensis (L.) Kuntze, Theaceae. – C. sinensis is a rich source of polyphenols. 
Epigallocatechin and epigallocatechin gallate are the most abundant polyphenols but the 
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composition might vary depending on leaf processing method (25). Green tea polyphenols 
have been shown to possess antioxidant, antiproliferative, proapoptotic, antiviral and 
 antitumor properties (26).
Ointment with green tea extract, comprised of more than 85 % catechins, is a patient-
administered therapy for external genital warts. Phase III clinical trials demonstrated 
significantly higher efficacy and lower recurrence rates compared to other currently 
available patient-applied treatments. In two identically designed, randomized, double-
blind, Phase III trials, a total of 1005 participants (535 men and 470 women) were included 
to receive 15 % green tea extract ointment, 10 % green tea extract ointment or vehicle. 
Treatment was applied at 8-hour intervals three times a day for 16 weeks or until complete 
resolution of all baseline warts was observed. Rates of complete clearance of all warts in 
both green tea extract ointment groups were significantly superior to vehicle (Ps < 0.001). 
The median time to complete wart clearance in the two trials was 16 weeks and 10 weeks in 
the 15 % and 10 % green tea extract ointment groups, respectively. In all studies, recurrence 
rates were low and complete clearance rates were higher in women than in men (27).
Podophyllum peltatum L., Berberidaceae. – P. peltatum has been used for centuries in 
the treatment of warts and skin cancers by indigenous people of the Americas. Podophyllin 
is a resin extracted from the root of the P. peltatum (28). When treating genital warts, a 
recent study showed that a combination of cryotherapy and podophyllin therapy is more 
efficient than cryotherapy alone, shortening the treatment regimen (29). According to a 
meta-analysis of 9 randomised controlled trials, podophyllotoxin, the main ingredient of 
podophyllin, in the concentration of 0.5 % caused complete clearance of genital warts in 
56.41 % of patients. Burning sensation, pain, pruritus and inflammation might occur on 
the site of application (28).
CONCLUSIONS
Medicinal plants have been used for the treatment of skin conditions long before 
synthetic drugs came on the market. Advantages of synthetic drugs for prescribers are 
reliable scientific background, quality and stability of the product, which is ensured by 
legislative means. Although herbal medicinal products can only strive to achieve a quality 
level comparable to conventional therapy, certain advantages cannot be ignored. Firstly, 
described medicinal plants have a better safety profile, with the exception of Ginkgo – 
conventional therapeutic for indications other than vitiligo, with well-known side-effects 
and potential interactions. Secondly, multiple pharmacological targets are modulated with 
a complex mixture of plant metabolites, thereby providing a possible solution for diseases 
resistant to conventional therapy.
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